AUGMENTIN 1gm In Skin And Soft Tissue Infection
Launched by GLAXOSMITHKLINE · Jun 20, 2006
Trial Information
Current as of June 07, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • having diagnosed uncomplicated soft tissue infection (e.g furuncle, cellulitis)
- • has given freely documented consent.
- Exclusion Criteria:
- • antibiotics
- • have renal or hepatic insufficiency
- • systemic toxicity
- • pregnancy
- • lactation
- • hypersensitivity to penicillin or Beta-lactam antibiotics
About Glaxosmithkline
GlaxoSmithKline (GSK) is a global healthcare company dedicated to improving the quality of human life by enabling people to do more, feel better, and live longer. With a strong focus on research and development, GSK specializes in pharmaceuticals, vaccines, and consumer health products. The company is committed to advancing innovative therapies and preventive measures across various therapeutic areas, including respiratory, oncology, immunology, and infectious diseases. GSK's collaborative approach and rigorous clinical trial processes underscore its dedication to delivering safe and effective healthcare solutions that meet the needs of patients worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lahore, , Pakistan
Karachi, , Pakistan
Patients applied
Trial Officials
GSK Clinical Trials
Study Director
GlaxoSmithKline
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials